文献速递艾滋病与性传播感染病毒性肝炎

HIV感染者隐匿性肝硬化的肝脏相关事件研究

Liver-related Events in Human Immunodeficiency Virus-infected Persons With Occult Cirrhosis.
PubMed 文献 · Clin Infect Dis · 2019-01-01

加拿大两个HIV感染者队列通过瞬时弹性成像分类为隐匿性肝硬化、显性肝硬化和无肝硬化,中位随访1.8年发现隐匿性肝硬化患者肝脏相关事件发生率显著高于无肝硬化者,且肝癌监测率低于显性肝硬化患者。

要点

  • 隐匿性肝硬化定义为TE≥13 kPa且无血小板减少及影像/内镜肝硬化征象。
  • 隐匿性肝硬化患者肝脏相关事件发生率为34.0/1000人年,显著高于无肝硬化者。
  • 隐匿性肝硬化患者肝癌监测率仅24%,低于显性肝硬化的40%。

核心结论

  • HIV感染者中隐匿性肝硬化患者肝脏相关事件发生率高,需加强监测和早期识别。

研究设计与样本

  • 加拿大两个HIV感染者队列,共1092例,51%合并丙型肝炎病毒,通过瞬时弹性成像分类并随访。

主要发现

  • 基线隐匿性肝硬化和显性肝硬化患病率分别为2.7%和10.7%。
  • 中位随访1.8年,无肝硬化、隐匿性肝硬化和显性肝硬化肝脏相关事件发生率分别为3.4、34.0和37.0/1000人年。
  • 基线隐匿性肝硬化(aHR 7.1,95%CI 1.3-38.0)和显性肝硬化(aHR 8.5,95%CI 2.8-26.0)与肝脏相关事件独立相关。

关键数值与推荐

  • 隐匿性肝硬化定义为TE≥13 kPa且无血小板减少及超声或胃镜示晚期肝病征象。
  • 显性肝硬化定义为TE≥13 kPa且有肝硬化征象。

临床怎么用

  • 对HIV感染者应通过瞬时弹性成像识别隐匿性肝硬化,并提高肝癌监测率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human immunodeficiency virus (HIV)-infected patients are at increased risk of liver-related mortality. The effect of occult cirrhosis (OcC), defined as preclinical compensated cirrhosis without any clinical findings, on liver-related events is unknown. METHODS: HIV-infected patients from 2 Canadian cohorts underwent transient elastography (TE) examination and were classified as (1) OcC (TE ≥13 kPa with no sign of cirrhosis, including absence of thrombocytopenia and signs of advanced liver disease on ultrasound or gastroscopy); (2) overt cirrhosis (OvC) (TE ≥13 kPa with signs of cirrhosis); or (3) noncirrhotic patients (TE <13 kPa). Incidence and risk factors of liver-related events were investigated through Kaplan-Meier and Cox regression analyses, respectively. We estimated monitoring rates according to screening guidelines for hepatocellular carcinoma (HCC) by OcC and OvC status. RESULTS: A total of 1092 HIV-infected patients (51% coinfected with hepatitis C virus) were included. Prevalence of OcC and OvC at baseline was 2.7% and 10.7%, respectively. During a median follow-up of 1.8 (interquartile range, 1.5-2.8) years, the incidence of liver-related events in noncirrhosis, OcC, and OvC was 3.4 (95% confidence interval [CI], 1.2-7.3), 34.0 (95% CI, 6.0-104.0), and 37.0 (95% CI, 17.0-69.1) per 1000 person-years, respectively. Baseline OcC (adjusted hazard ratio [aHR], 7.1 [95% CI, 1.3-38.0]) and OvC (aHR, 8.5 [95% CI, 2.8-26.0]) were independently associated with liver-related events. Monitoring rates for HCC were lower in patients with OcC (24%) compared to those with OvC (40%). CONCLUSIONS: HIV-infected patients with OcC have a high incidence of liver-related events. Greater surveillance and earlier recognition with appropriate screening strategies are necessary for improved outcomes.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Benmassaoud A, Nitulescu R, Pembroke T, et al. Liver-related Events in Human Immunodeficiency Virus-infected Persons With Occult Cirrhosis. Clin Infect Dis. 2019. PMID: 30561558. doi:10.1093/cid/ciy1082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。